Gangolli Julian S Insider Trades

Insider Trading History

Track insider trading activity for Gangolli Julian S. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
Director
Holding Value $8.6k 286,734 shares
Last Trade
Oct 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.6k 286,734 shares
$0.03
$0.03
Outlook Therapeutics
Outlook Therapeutics OTLK
Director
Holding Value $228k 286,734 shares
Last Trade
Oct 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$298k 286,734 shares
$1.04
$0.79
Krystal Biotech
Krystal Biotech KRYS
Director
Holding Value $1.54M 5,000 shares
Last Trade
Jun 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$687k 5,000 shares
$137.46
$307.79
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $0 0 shares
Last Trade
Feb 06, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$54.8k 15,000 shares
$3.65
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $54.8k 15,000 shares
Last Trade
Feb 04, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$110k 30,106 shares
$3.65
$3.65
Outlook Therapeutics
Outlook Therapeutics OTLK
Director
Holding Value $56.6k 71,169 shares
Last Trade
Oct 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$667k 127,805 shares
$5.22
$0.79
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
Director
Holding Value $2.14k 71,169 shares
Last Trade
Oct 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.83k 127,805 shares
$0.03
$0.03
Krystal Biotech
Krystal Biotech KRYS
Director
Holding Value $1.54M 5,000 shares
Last Trade
Jun 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$918k 5,000 shares
$183.64
$307.79
Krystal Biotech
Krystal Biotech KRYS
Director
Holding Value $6.16M 20,000 shares
Last Trade
May 20, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.29M 20,000 shares
$164.45
$307.79
Krystal Biotech
Krystal Biotech KRYS
Director
Holding Value $2.79M 9,070 shares
Last Trade
May 20, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.28M 20,000 shares
$164.14
$307.79
Krystal Biotech
Krystal Biotech KRYS
Director
Holding Value $0 0 shares
Last Trade
May 20, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.29M 20,000 shares
$164.45
$307.79
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $165k 45,106 shares
Last Trade
May 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$89.1k 23,458 shares
$3.80
$3.65
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
Director
Holding Value $2.83k 94,441 shares
Last Trade
Mar 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.83k 94,441 shares
$0.03
$0.03
Outlook Therapeutics
Outlook Therapeutics OTLK
Director
Holding Value $75.1k 94,441 shares
Last Trade
Mar 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$38.7k 94,441 shares
$0.41
$0.79
Outlook Therapeutics
Outlook Therapeutics OTLK
Director
Holding Value $294k 370,282 shares
Last Trade
Oct 04, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$88.9k 370,282 shares
$0.24
$0.79
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
Director
Holding Value $11.1k 370,282 shares
Last Trade
Oct 04, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.1k 370,282 shares
$0.03
$0.03
Krystal Biotech
Krystal Biotech KRYS
Director
Holding Value $2.09M 6,800 shares
Last Trade
Jun 30, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$798k 6,800 shares
$117.40
$307.79
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $110k 30,106 shares
Last Trade
May 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$199k 5,915 shares
$33.61
$3.65
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
Director
Holding Value $1.23k 41,065 shares
Last Trade
Mar 29, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.23k 41,065 shares
$0.03
$0.03
Outlook Therapeutics
Outlook Therapeutics OTLK
Director
Holding Value $32.6k 41,065 shares
Last Trade
Mar 29, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$43.1k 41,065 shares
$1.05
$0.79

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up